The Beneficial Effects of Empagliflozin, an SGLT2 Inhibitor, on Atherosclerosis in ApoE −/− Mice Fed a Western Diet
Diabetologia - Germany
doi 10.1007/s00125-016-4158-2
Full Text
Open PDFAbstract
Available in full text
Date
November 19, 2016
Authors
Publisher
Springer Science and Business Media LLC